margetuximab

E2190156 UNEXPLORED

Margetuximab is an Fc-engineered monoclonal antibody drug designed to enhance immune-mediated targeting and destruction of HER2-positive cancer cells.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
margetuximab canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

CD340 → targetOf → margetuximab ⓘ